Lead in Consumer Products: Insights from New York City and Massachusetts
Boston Children’s Hospital and the New England Region One Pediatric Environmental Health Specialty Unit are offering a monthly online Grand R…
Lead is a neurotoxicant that adversely affects neurodevelopment even at low exposure levels. Adverse outcomes associated with prenatal or early life exposure include ADHD, delayed learning and growth, lower IQ, developmental and behavioral problems, hypertension, hearing loss, renal dysfunction, and reproductive issues.
Children under 6 years of age have unique behaviors and physiology that increase their risk for exposure to lead and subsequent adverse developmental and health outcomes. Most children with elevated blood lead levels are asymptomatic or have nonspecific symptoms.
Blood lead testing is the best way to identify lead-exposed children. Evaluate for lead exposure risk factors at well-child visits from 6 months to 6 years and as early as possible in pregnant women and provide anticipatory guidance on exposure prevention. Perform blood lead testing in accordance with federal, local, and state requirements and recommendations. Recognition and timely interventions can reduce harm and improve outcomes for lead-exposed children and pregnant women. Health professionals play a key role in preventing exposure, identifying and treating lead poisoning in patients, and advocating for public health measures to address the problem.
The Good News: Lead poisoning is preventable.
References:
Contact your regional PEHSU to speak with a specialist if you have questions not addressed by the FAQs or would like guidance managing care for a lead-exposed child or pregnant or breastfeeding woman.
Receive periodic program updates and get the latest research and insights from our environmental health experts on reproductive and pediatric health.